Cargando…

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy

Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular carcinoma (HCC). The aim of this study was to explore the incidence of HCC in a cohort of subjects with HBV and correlate with HBV treatment current guidance. We identified 2846 subjects with HBV over the study p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshuwaykh, Omar, Daugherty, Tami, Cheung, Amanda, Goel, Aparna, Dhanasekaran, Renumathy, Ghaziani, T. Tara, Ahmed, Aijaz, Dronamraju, Deepti, Kumari, Radhika, Kwong, Allison, Nguyen, Mindie, Kim, W. Ray, Kwo, Paul Yien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592790/ https://www.ncbi.nlm.nih.gov/pubmed/36004713 http://dx.doi.org/10.1002/hep4.2064

Ejemplares similares

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites
por: Alshuwaykh, Omar, et al.
Publicado: (2022)

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
por: Alshuwaykh, Omar, et al.
Publicado: (2020)

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
por: Kwo, Paul, et al.
Publicado: (2020)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Current and future strategies for the treatment of chronic hepatitis C
por: Alshuwaykh, Omar, et al.
Publicado: (2021)

HCV treatment in 2020: How to translate highly effective therapies into elimination strategies
por: Alshuwaykh, Omar, et al.
Publicado: (2020)

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
por: Aggarwal, Avin, et al.
Publicado: (2017)

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
por: Adeniji, Nia, et al.
Publicado: (2021)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Chinese Skullcap in Move Free Arthritis Supplement Causes Drug Induced Liver Injury and Pulmonary Infiltrates
por: Dhanasekaran, Renumathy, et al.
Publicado: (2013)

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
por: Dhanasekaran, Renumathy, et al.
Publicado: (2016)

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
por: Cholankeril, George, et al.
Publicado: (2017)

Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022)

Rare Case of Adult Undifferentiated (Embryonal) Sarcoma of the Liver Treated with Liver Transplantation: Excellent Long-Term Survival
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023)

Primary Biliary Cirrhosis: Environmental Risk Factors
por: Dronamraju, Deepti, et al.
Publicado: (2010)

Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
por: Yang, Christine Hong Ting, et al.
Publicado: (2018)

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases
por: Adeniji, Nia, et al.
Publicado: (2021)

Impact of COVID-19 on the liver transplant activity in the US: variation by the region, etiology, and cirrhosis complications
por: Singal, Ashwani, et al.
Publicado: (2022)

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
por: Lai, Ian, et al.
Publicado: (2018)

Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome
por: Gupta, Tina, et al.
Publicado: (2021)

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
por: Nguyen, Vy H., et al.
Publicado: (2022)

Antiviral Perspectives for Chikungunya Virus
por: Parashar, Deepti, et al.
Publicado: (2014)

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis
por: Perumpail, Brandon J., et al.
Publicado: (2017)

A Case of Heyde Syndrome with Resolution of Gastrointestinal Bleeding Two Weeks After Aortic Valve Replacement
por: Alshuwaykh, Omar, et al.
Publicado: (2018)

Why Gayborhoods Matter: The Street Empirics of Urban Sexualities
por: Ghaziani, Amin
Publicado: (2020)

The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C
por: Yang, Christine Hong Ting, et al.
Publicado: (2017)

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia
por: Wei, Bin, et al.
Publicado: (2018)

Viral Hepatitis Other than A, B, and C: Evaluation and Management
por: Cheung, Amanda, et al.
Publicado: (2020)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

Enterovirus 71 seroepidemiology in Taiwan in 2017 and comparison of those rates in 1997, 1999 and 2007
por: Lee, Jian-Te, et al.
Publicado: (2019)

Those who leave and those who stay /
por: Ferrante, Elena
Publicado: (2014)

Application of Polyvinyl chloride sheet as delayed surgical obturator in maxillectomy defects secondary to mucormycosis- A case series
por: Deepika, Kumari, et al.
Publicado: (2023)

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

The nonlinearity of pupil diameter fluctuations in an insight task as criteria for detecting children who solve the problem from those who do not
por: Vásquez-Pinto, Sebastián, et al.
Publicado: (2023)

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
por: Nguyen, Peter, et al.
Publicado: (2017)

An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
por: Panda, Kingshuk, et al.
Publicado: (2023)

Antiviral & platelet-protective properties of Carica papaya in dengue
por: Shrivastava, Nidhi, et al.
Publicado: (2022)

GMO debate: inconclusive
por: Dronamraju, Krishna
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a0ddo6qesoor3id1cfps9r231m